1nak:H (GLU1) to (SER112) IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE)) | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1nak:I (GLU1) to (SER112) IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE)) | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2ajs:H (GLU1) to (VAL111) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL | CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, HEPTAETHYLENE GLYCOL, IMMUNE SYSTEM
2aju:H (VAL2) to (SER112) CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' | CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, IMMUNE SYSTEM
2ajv:H (LYS3) to (SER112) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE | CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, IMMUNE SYSTEM
2ajy:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID | CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, BENZOIC ACID, HYDROLYTIC, IMMUNE SYSTEM
2ak1:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID | CATALYTIC ANTIBODY, FAB, BENZOIC ACID, HYDROLYTIC, IMMUNE SYSTEM
1nby:B (GLU301) to (VAL411) CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A | ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
1nbz:B (GLU301) to (SER412) CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A | ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2apt:A (ALA3) to (LEU117) CRYSTAL STRUCTURE OF THE G17E/S54N/K66E/Q72H/E80V/L81S/T87S/G96V VARIANT OF THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN | THE MURINE T CELL RECEPTOR V BETA 8.2 DOMAIN, IMMUNE SYSTEM
4wht:A (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:E (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:G (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:K (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:O (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:Q (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:S (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:U (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4wht:X (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
1nj9:L (ALA2) to (LEU107) COCAINE HYDROLYTIC ANTIBODY 15A10 | IMMUNOGLOBULIN, IMMUNE SYSTEM
1nma:L (ILE2) to (ARG108) N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA | COMPLEX (HYDROLASE-IMMUNOGLOBULIN), COMPLEX (HYDROLASE- IMMUNOGLOBULIN) COMPLEX
2op4:L (ALA2) to (LEU106) CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9 | IMMUNOGLOBULIN, ANTIBODY, FAB, INDUCED FIT, QUORUM SENSING, HOMOSERINE LACTONE, IMMUNE SYSTEM
3rvw:D (GLU1) to (SER120) CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 | ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
4h1l:H (GLY1) to (VAL111) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBIN FOLD, TCR RECOGNITON OF MHC, MHC II, GLYCOSIDATION, MEMBRANE, IMMUNE SYSTEM
4h1l:J (GLY1) to (VAL111) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBIN FOLD, TCR RECOGNITON OF MHC, MHC II, GLYCOSIDATION, MEMBRANE, IMMUNE SYSTEM
2b2x:H (GLN3) to (SER117) VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB | COMPUTATIONAL DESIGN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
2otu:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
1nsn:H (VAL2) to (SER112) THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, STAPHYLOCOCCAL NUCLEASE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) COMPLEX
4wuu:E (GLN3) to (SER120) STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1 | ANTIBODY, MHC 1, WT1, HLA-A*0201, IMMUNE SYSTEM
4hc1:H (ASP1) to (SER117) CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
4hc1:M (ASP1) to (SER117) CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
2bfv:H (VAL2) to (VAL117) MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI | IMMUNOGLOBULIN, FV FRAGMENT, STEROID HORMONE, FINE SPECIFICITY
3s34:H (GLN3) to (SER115) STRUCTURE OF THE 1121B FAB FRAGMENT | VEGF RECEPTOR DOMAIN 3, IMMUNE SYSTEM
3s37:H (VAL2) to (SER115) STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES | ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4x7t:A (GLN3) to (VAL119) STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2 | ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM
1bvk:E (VAL2) to (VAL114) HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME | HUMANIZED ANTIBODY, ANTIBODY COMPLEX, FV, ANTI-LYSOZYME, COMPLEX (HUMANIZED ANTIBODY/HYDROLASE)
1oax:M (ALA2) to (LEU109) FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE | IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE
1oaz:L (ALA2) to (LEU109) IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN | IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECFICITY, REDOX-ACTIVE CENTER, ELECTRON TRANSPORT
1oaz:N (ALA2) to (LEU109) IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN | IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECFICITY, REDOX-ACTIVE CENTER, ELECTRON TRANSPORT
1c12:B (VAL302) to (SER412) INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE | ANTIBODY-ANTIGEN COMPLEX, SCFV FRAGMENT, CDRH3, MUSK ODORANT, ODORANT SPECIFICITY, IMMUNE SYSTEM
1cd0:B (ASN1) to (LEU107) STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO | IMMUNOGLOBULIN, BENCE-JONES PROTEIN, LAMDA-6, IMMUNE SYSTEM
2pxy:B (ALA3) to (LEU117) CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES | COMPLEX, IMMUNE SYSTEM
1osp:H (GLU1) to (SER119) CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB | COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN), OUTER SURFACE PROTEIN A COMPLEXED WITH FAB184.1, BORRELIA BURGDORFERI STRAIN B31, COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN) COMPLEX
2cd0:A (ASN1) to (GLY108) STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL | IMMUNOGLOBULIN, BENCE-JONES PROTEIN, LAMBDA-6, IMMUNE SYSTEM
3g5v:B (ASP1) to (SER115) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
3g5x:D (VAL2) to (SER113) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
3g6a:L (TYR2) to (VAL106) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607 | IL-13, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3g6a:B (VAL2) to (SER121) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607 | IL-13, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3g6d:H (VAL2) to (SER121) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO607 FAB AND IL-13 | IL-13, ANTIBODY, COMPLEX, EPITOPE, CYTOKINE, GLYCOPROTEIN, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2qqn:H (GLN3) to (SER112) NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, HEPARAN SULFATE, MEMBRANE, NEUROGENESIS, PROTEOGLYCAN, SECRETED, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
1dqq:D (GLU1) to (VAL111) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 | ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
1qfw:M (ILE202) to (ILE306) TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT | GLYCOPROTEIN HORMONE, STIMULATION OF PRODUCTION OF PROGESTERONE, FVS SPECIFICALLY DIRECTED AGAINST ALPHA AND BETA SUBUNIT, IMMUNE SYSTEM
1etz:L (ALA2) to (LEU109) THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS | ANTI-SWEETENER FAB, ANTIGEN-ANTIBODY, COMPLEX, CRYSTAL STRUCTURE, RECEPTOR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM
1f4w:L (GLN1) to (LEU109) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1f4w:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1f4y:L (ALA2) to (LEU109) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1f8t:H (GLY1) to (VAL111) FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL, IMMUNE SYSTEM
1f90:H (GLN3) to (SER112) FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, ANTIGENIC PEPTIDE, IMMUNE SYSTEM
3he6:D (ALA3) to (GLU118) CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR | MOUSE CD1D, MOUSE NKT T-CELL RECEPTORS, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, IMMUNE SYSTEM
3hfm:H (VAL2) to (SER112) STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX | COMPLEX(ANTIBODY-ANTIGEN)
3hi5:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57 | FAB FRAGMENT, LIGAND MIMETIC, INTEGRIN, I DOMAIN, CELL ADHESION, IMMUNE SYSTEM
1fo0:A (LYS2) to (PRO116) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, IMMUNE SYSTEM
2v7n:D (GLN3) to (SER148) UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4 | BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM
1rhh:B (LEU4) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION | FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM
1rhh:D (LEU4) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION | FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM
3ulu:D (GLN3) to (VAL120) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
4khx:L (ILE2) to (VAL107) CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062 | IMMUNE SYSTEM, GP41
2vis:A (ALA2) to (LEU109) INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN), GLYCOPROTEIN, COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN) COMPLEX
3utz:B (VAL2) to (VAL117) ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL | STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM
3utz:C (LYS3) to (VAL117) ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL | STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM
4z7w:E (SER3) to (PRO128) T316 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7w:F (GLY3) to (GLU128) T316 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7w:H (GLY3) to (GLU128) T316 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z8f:H (VAL2) to (SER112) FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-P5(DT)P- 3' | ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM-DNA COMPLEX
4z95:H (VAL2) to (SER112) FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-5(DT)-P- 3' | ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM, IMMUNE SYSTEM-DNA COMPLEX
3huj:F (ASP3) to (GLU118) CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR | CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1sbs:H (VAL2) to (VAL121) CRYSTAL STRUCTURE OF AN ANTI-HCG FAB | MONOCLONAL ANTIBODY, FAB-FRAGMENT, REPRODUCTION
2g75:D (TYR3) to (VAL106) CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY | SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM
2w0k:A (ASN1) to (LEU111) CRYSTAL STRUCTURE OF THE RECOMBINANT VARIABLE DOMAIN 6JAL2 | FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM
1hq4:B (ASP1) to (SER112) STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4 | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM
1tvd:A (LYS2) to (PRO116) VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN | IMMUNORECEPTOR, TCR, DELTA CHAIN, VARIABLE DOMAIN
4llw:A (VAL2) to (SER118) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A | FAB, IMMUNE SYSTEM
5a2k:H (ILE1003) to (GLY1107) CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-TGALNAC-RP | IMMUNE SYSTEM, GLYCOPEPTIDES, ANTIBODIES, MOLECULAR RECOGNITION, CONFORMATION ANALYSIS, FUSION PROTEIN
1i9i:H (VAL2) to (SER117) NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT | FAB FRAGMENT, ANTI-TESTOSTERONE, RECOMBINANT, MONOCLONAL, IMMUNE SYSTEM
1i9j:H (VAL2) to (SER117) TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT | FAB FRAGMENT, ANTI-TESTOSTERONE, RECOMBINANT, MONOCLONAL, TESTOSTERONE, IMMUNE SYSTEM
1ic7:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A99A)-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, PROTEIN BINDING/HYDROLASE COMPLEX
1ic5:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD99A)-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, PROTEIN BINDING/HYDROLASE COMPLEX
1igj:D (VAL2) to (VAL111) 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY | IMMUNOGLOBULIN
1igt:B (VAL2) to (VAL111) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN
4mau:H (VAL2) to (VAL115) CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
1j1p:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
2xkn:D (VAL2) to (SER115) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7 | IMMUNE SYSTEM, IMMUNOGLOBULIN
5ayu:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV | IMMUNE SYSTEM
1kfa:I (MET3) to (SER120) CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4 | IMMUNOGLOBUILN FOLD, IMMUNE SYSTEM
2ybr:A (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
2ybr:G (GLN3) to (VAL115) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
2yc1:A (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
2yc1:D (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
1xgp:B (VAL2) to (VAL111) STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A RESOLUTION, Y33A MUTANT, IMMUNE SYSTEM
1xgq:B (GLU1) to (VAL111) STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A RESOLUTION, Y33V MUTANT, IMMUNE SYSTEM
1lo0:Y (VAL2) to (SER118) CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX | CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1lo0:H (VAL2) to (SER118) CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX | CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1lo2:Y (VAL2) to (SER118) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY | CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM
1lo2:H (VAL2) to (SER118) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY | CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM
1lo3:H (VAL2) to (SER118) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE | FAB, CATALYTIC ANTIBODY, PRODUCT COMPLEX, IMMUNE SYSTEM
2z91:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 | IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM
2z91:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 | IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM
2z92:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE | IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM
2znw:A (ASP123) to (SER234) CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME | SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX
2znw:B (ASP123) to (SER234) CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME | SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX
2zpk:L (THR2) to (LEU107) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
2zpk:M (THR2) to (LEU107) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
1mfa:L (ILE2) to (LEU109) STRUCTURE OF A SINGLE-CHAIN FV FRAGMENT COMPLEXED WITH A CARBOHYDRATE ANTIGEN AT 1.7 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
4p5t:E (GLN2) to (TYR111) 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE | MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM
1yc8:A (VAL2) to (SER117) CABAN33- Y37V/E44G/R45L TRIPLE MUTANT | ANTIBODY, CAMEL ANTIBODY, IMMUNE SYSTEM
3a6b:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN32D COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM-HYDROLASE COMPLEX, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISULFIDE BOND, GLYCOSIDASE
3ab0:E (VAL2) to (SER115) CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT | EXOSPORIUM, ANTHRAX, TBCLA, SCFV COMPLEX, IMMUNE SYSTEM
5dlm:H (GLN1) to (VAL113) COMPLEX OF INFLUENZA M2E AND ANTIBODY | COMPLEX, ANTIBODY, EXTRACELLULAR DOMAIN, IMMUNE SYSTEM
5dlm:I (VAL2) to (VAL113) COMPLEX OF INFLUENZA M2E AND ANTIBODY | COMPLEX, ANTIBODY, EXTRACELLULAR DOMAIN, IMMUNE SYSTEM
3ley:H (ASP1) to (SER111) 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41 | HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN
5e2w:H (VAL2) to (SER112) ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE | IMMUNE SYSTEM
5e8e:B (GLN3) to (ALA124) CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB | IMMUNE SYSTEM-HYDROLASE COMPLEX, IMMUNE SYSTEM, INHIBITOR
2a1w:H (VAL2) to (SER122) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I | IMMUNE SYSTEM
2a77:H (LYS3) to (ALA121) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II | IMMUNE SYSTEM
2adj:A (THR2) to (ILE106) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM | ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM
3bdx:A (ASN1) to (VAL110) CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2 | LAMBDA VI SUBGROUP, LIGHT CHAIN VARIABLE DOMAIN, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM
4qrp:K (ASP1) to (PRO124) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
3bn9:F (GLN3) to (SER112) CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2 | ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE
5fgc:B (TYR2) to (VAL106) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, VIRAL PROTEIN
3cfj:L (LEU2) to (ILE106) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfj:C (LEU2) to (ILE106) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3nn8:D (VAL2) to (SER121) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
4ckd:H (ASP1) to (SER112) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:I (ASP1) to (SER112) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:J (ASP1) to (SER112) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:K (ASP1) to (SER112) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
3cxh:U (LYS3) to (THR119) STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER. | COMPLEX III, CYTOCHROME C ISOFORM-2, ELECTRON TRANSFER COMPLEX, CYTOCHROME BC1 COMPLEX, MITOCHONDRIALTRANSMEMBRANE COMPLEX, RESPIRATORY CHAIN, TRANSIENT PROTEIN-PROTEIN INTERACTION, ELECTRON TRANSPORT, INNER MEMBRANE, MITOCHONDRION, TRANSIT PEPTIDE, TRANSPORT, PHOSPHOPROTEIN, HEME, IRON, METAL-BINDING, IRON-SULFUR, OXIDOREDUCTASE
3o6l:H (VAL2) to (SER116) ANTI-TAT HIV 11H6H1 FAB' COMPLEXED WITH A 15-MER TAT PEPTIDE | ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV
5gs0:D (GLN3) to (THR119) CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, COMPLEX, IMMUNE SYSTEM
5gs0:X (GLN3) to (VAL114) CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, COMPLEX, IMMUNE SYSTEM
5gs0:H (GLN3) to (SER115) CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, COMPLEX, IMMUNE SYSTEM
4dgv:H (VAL2) to (SER112) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, P2(1) FORM | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
5hi3:D (ASN1) to (VAL106) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi3:L (ASN1) to (VAL106) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
3p9w:D (GLN3) to (SER112) CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF | VH, CYSTINE KNOT CYTOKINE, VEGF-R, SIGNALING PROTEIN, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5i1d:B (VAL2) to (VAL117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4f37:H (THR3) to (SER124) STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE | AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM
4v1d:A (VAL2) to (VAL115) TERNARY COMPLEX AMONG TWO HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENTS AND CN2 TOXIN FROM SCORPION CENTRUROIDES NOXIUS. | TOXIN-IMMUNE SYSTEM COMPLEX, HUMAN SCFV, SCORPION VENOM NEUTRALIZATION, DIRECTED EVOLUTION, CN2 TOXIN.
4v1d:D (ASN3) to (SER123) TERNARY COMPLEX AMONG TWO HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENTS AND CN2 TOXIN FROM SCORPION CENTRUROIDES NOXIUS. | TOXIN-IMMUNE SYSTEM COMPLEX, HUMAN SCFV, SCORPION VENOM NEUTRALIZATION, DIRECTED EVOLUTION, CN2 TOXIN.
4fql:H (VAL2) to (SER112) INFLUENZA B HA ANTIBODY (FAB) CR8033 | FAB FRAGMENT, MONOCLONAL, VIRAL, IMMUNOGLOBULIN, INFLUENZA B VIRUS, IMMUNE SYSTEM
4g6j:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB | IMMUNGLOBULIN FOLD, INTERLEUKIN-1BETA BINDING, IMMUNE SYSTEM
4hdi:H (VAL2) to (VAL118) CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS | IGG, FAB, IMMUNE SYSTEM
4hg4:X (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1pkq:A (ASP1) to (THR109) MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX | AUTOANTIBODY, MULTIPLE SCLEROSIS, EAE, IMMUNE SYSTEM
4xx1:H (GLN3) to (SER125) LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1 | A/B HYDROLASE, COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
1dql:H (VAL2) to (VAL121) CRYSTAL STRUCTURE OF AN UNLIGANDED (NATIVE) FV FROM A HUMAN IGM ANTI-PEPTIDE ANTIBODY | IMMUNOGLOBULIN FOLD, ANTIBODY, IGM, FV, IMMUNE SYSTEM
1dqm:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY | ANTIBODY, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
4y5x:A (VAL2) to (SER123) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
1q0x:L (ALA2) to (LEU106) ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM | ANTI-MORPHINE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
3ve0:A (VAL2) to (SER118) CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6 | EBOLA, SUDAN, GLYCOPROTEIN, VIRUS SURFACE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3ifl:H (VAL2) to (SER119) X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
2xa8:H (GLN3) to (VAL119) CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A | XOLAIR, ALLERGY, IMMUNE SYSTEM
1kcu:H (GLN1) to (SER115) CRYSTAL STRUCTURE OF ANTIBODY PC287 | ANTI-PEPTIDE ANTIBODY, IMMUNE SYSTEM
5c7x:M (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
2zuq:C (VAL2) to (SER118) CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX | DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX
2zuq:F (VAL2) to (SER118) CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX | DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX
4p23:A (GLN2) to (PRO111) J809.B5 TCR BOUND TO IAB/3K | TCR MHC PEPTIDE, IMMUNE SYSTEM
4p59:H (GLN3) to (VAL115) HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825 | HER3 RECEPTOR, THERAPEUTIC ANTIBODY, FAB FRAGMENT, ANTI-HER3, SIGNALING PROTEIN, IMMUNE SYSTEM
5d71:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOR04302, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
3ks0:L (ALA2) to (LEU109) CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4 | ELECTRON TRANSFER, EPITOPE, DOMAIN MOBILITY, FLAVOCYTOCHROME B2, ANTIBODY, FAB, HEME DOMAIN, ELECTRON TRANSPORT, FLAVOPROTEIN, FMN, HEME, METAL-BINDING, MITOCHONDRION, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSIT PEPTIDE, TRANSPORT
3a67:H (ASP1) to (SER112) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN31D COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM-HYDROLASE COMPLEX, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISULFIDE BOND, GLYCOSIDASE
5e2u:H (GLN3) to (PRO119) STRUCTURE OF ANTI-TAU AT8 FAB IN THE PRESENCE OF PHOSPHOPEPTIDE | IMMUNE SYSTEM
5i1a:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1a:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM